.Merck trumps revenues expectations, raises purchases expectation on powerful need for leading medications like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Estimates as Keytruda Purchases Surge BloombergMerck Supply: Pharma Titan Posts Sturdy Results, Yet Expectation Drops Short Investor's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps income and purchases requirements surrounded by Keytruda strong point, yet delivers combined full-year overview MarketWatch.